Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.850
+0.010 (0.35%)
At close: Dec 20, 2024, 4:00 PM
3.000
+0.150 (5.26%)
After-hours: Dec 20, 2024, 7:57 PM EST
Perspective Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 1.56 | 1.43 | 5.42 | - | 10.05 | 9.68 | Upgrade
|
| Revenue Growth (YoY) | - | -73.52% | - | - | 3.85% | 32.35% | Upgrade
|
| Cost of Revenue | - | - | 3.05 | - | 4.93 | 4.56 | Upgrade
|
| Gross Profit | 1.56 | 1.43 | 2.37 | - | 5.12 | 5.12 | Upgrade
|
| Selling, General & Admin | 23.31 | 21.06 | 9.35 | 5.57 | 7.13 | 7.55 | Upgrade
|
| Research & Development | 35.84 | 21.31 | 1.81 | 0.85 | 1.43 | 1.13 | Upgrade
|
| Other Operating Expenses | 0.02 | - | - | - | - | -0.07 | Upgrade
|
| Operating Expenses | 59.16 | 42.38 | 11.17 | 6.42 | 8.56 | 8.6 | Upgrade
|
| Operating Income | -57.6 | -40.94 | -8.8 | -6.42 | -3.44 | -3.48 | Upgrade
|
| Interest Expense | -0.15 | -0.08 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 7.93 | 0.93 | 0.62 | 0.12 | 0.06 | 0.03 | Upgrade
|
| Earnings From Equity Investments | -0.01 | -0.02 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -49.83 | -40.11 | -8.18 | -6.3 | -3.38 | -3.45 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.04 | - | -0.31 | - | -0.01 | - | Upgrade
|
| Pretax Income | -49.86 | -40.11 | -8.49 | -6.3 | -3.39 | -3.45 | Upgrade
|
| Income Tax Expense | 7.85 | -2.65 | - | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -57.71 | -37.46 | -8.49 | -6.3 | -3.39 | -3.45 | Upgrade
|
| Earnings From Discontinued Operations | -6.07 | -9.05 | -2.28 | -0.97 | - | - | Upgrade
|
| Net Income | -63.79 | -46.51 | -10.76 | -7.27 | -3.39 | -3.45 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0 | 0.01 | Upgrade
|
| Net Income to Common | -63.79 | -46.51 | -10.76 | -7.27 | -3.39 | -3.46 | Upgrade
|
| Shares Outstanding (Basic) | 54 | 27 | 14 | 14 | 10 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 54 | 27 | 14 | 14 | 10 | 7 | Upgrade
|
| Shares Change (YoY) | 130.70% | 88.39% | 0.06% | 36.74% | 53.61% | 0.83% | Upgrade
|
| EPS (Basic) | -1.19 | -1.74 | -0.76 | -0.51 | -0.33 | -0.51 | Upgrade
|
| EPS (Diluted) | -1.19 | -1.74 | -0.76 | -0.51 | -0.33 | -0.51 | Upgrade
|
| Free Cash Flow | -40.59 | -37.99 | -10.68 | -7.98 | -3.22 | -3.91 | Upgrade
|
| Free Cash Flow Per Share | -0.76 | -1.42 | -0.75 | -0.56 | -0.31 | -0.58 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 43.71% | - | 50.94% | 52.93% | Upgrade
|
| Operating Margin | -3699.42% | -2855.02% | -162.47% | - | -34.19% | -35.91% | Upgrade
|
| Profit Margin | -4096.66% | -3243.24% | -198.71% | - | -33.72% | -35.71% | Upgrade
|
| Free Cash Flow Margin | -2606.62% | -2648.88% | -197.29% | - | -32.01% | -40.43% | Upgrade
|
| EBITDA | -55.76 | -39.96 | -8.48 | -6.14 | -3.23 | -3.27 | Upgrade
|
| EBITDA Margin | - | - | -156.56% | - | -32.10% | -33.78% | Upgrade
|
| D&A For EBITDA | 1.84 | 0.98 | 0.32 | 0.28 | 0.21 | 0.21 | Upgrade
|
| EBIT | -57.6 | -40.94 | -8.8 | -6.42 | -3.44 | -3.48 | Upgrade
|
| EBIT Margin | - | - | -162.47% | - | -34.19% | -35.91% | Upgrade
|
| Revenue as Reported | - | - | 5.42 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.